Table 3 Change in drug prescriptions and cost of drugs during 90 days before/after the first observed inpatient visit with diagnosis F43 for the integrative care and conventional care cohorts
Integrative Care (N = 161) | Conventional Care (N = 1571) | Conventional-Integrative | Conventional-Integrative | |
|---|---|---|---|---|
Change from 90-days before to 90-days after index visit | Difference in change between groups | Effect Size (Cohen’s d) | ||
DDDs/patient | ||||
ATC-N05A | −0.3 (−1.1 to 0.6), p = 0.518 | 0.7 (−0.2 to 1.6), p = 0.147 | 1.0 (−0.3 to 1.5), p = 0.515 | 0.1 (−0.1 to 0.2) |
ATC-N05B | −11.5 (−19.7 to −3.2), p = 0.003 | 16.9 (12.4 to 21.3), p < 0.001 | 28.3 (14.2 to 42.4), p < 0.001 | 0.3 (0.2 to 0.5) |
ATC-N05C | −2.1 (−3.6 to −0.6), p = 0.004 | 6.8 (5.5 to 8.1), p < 0.001 | 8.9 (4.8 to 13.0), p < 0.001 | 0.4 (0.2 to 0.5) |
ATC-N06A | −2.1 (−7.8 to 3.6), p = 0.473 | 10.4 (7.8 to 13.0), p < 0.001 | 12.5 (4.2 to 20.8), p < 0.001 | 0.2 (0.1 to 0.4) |
Cost/patient (EUR) | ||||
ATC-N05A | 5.3 (−11.9 to 22.6), p = 0.542 | 14.5 (7.7 to 21.4), p < 0.001 | 9.2 (−12.9 to 31.3), p = 0.415 | 0.1 (−0.1 to 0.2) |
ATC-N05B | −2.4 (−4.1 to −0.7), p = 0.003 | 3.2 (2.3 to 4.2), p < 0.001 | 5.6 (2.6 to 8.7), p < 0.001 | 0.3 (0.1 to 0.5) |
ATC-N05C | −2.2 (−3.5 to −0.8), p = 0.001 | 2.9 (2.1 to 3.7), p < 0.001 | 5.1 (2.4 to 7.7), p < 0.001 | 0.3 (0.2 to 0.5) |
ATC-N06A | −9.2 (−20.6 to 2.3), p = 0.058 | 13.0 (9.1 to 16.9), p < 0.001 | 22.2 (9.4 to 34.9), p < 0.001 | 0.3 (0.1 to 0.4) |